Hajiramezanali M - Search Results

1

Controlling evolution of protein corona: a prosperous approach to improve chitosan-based nanoparticle biodistribution and half-life.

Tekie FSM, Hajiramezanali M, Geramifar P, Raoufi M, Dinarvand R, Soleimani M, Atyabi F. Tekie FSM, et al. Among authors: hajiramezanali m. Sci Rep. 2020 Jun 15;10(1):9664. doi: 10.1038/s41598-020-66572-y. Sci Rep. 2020. PMID: 32541900 Free PMC article.

2

Optimization of chitosan-based polyelectrolyte nanoparticles for gene delivery, using design of experiment: in vitro and in vivo study.

Baghaei M, Tekie FSM, Khoshayand MR, Varshochian R, Hajiramezanali M, Kachousangi MJ, Dinarvand R, Atyabi F. Baghaei M, et al. Among authors: hajiramezanali m. Mater Sci Eng C Mater Biol Appl. 2021 Jan;118:111036. doi: 10.1016/j.msec.2020.111036. Epub 2020 Apr 30. Mater Sci Eng C Mater Biol Appl. 2021. PMID: 33254955

3

⁶⁸Ga-radiolabeled bombesin-conjugated to trimethyl chitosan-coated superparamagnetic nanoparticles for molecular imaging: preparation, characterization and biological evaluation.

Hajiramezanali M, Atyabi F, Mosayebnia M, Akhlaghi M, Geramifar P, Jalilian AR, Mazidi SM, Yousefnia H, Shahhosseini S, Beiki D. Hajiramezanali M, et al. Int J Nanomedicine. 2019 Apr 10;14:2591-2605. doi: 10.2147/IJN.S195223. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31040674 Free PMC article.

4

Trimethyl chitosan-hyaluronic acid nano-polyplexes for intravitreal VEGFR-2 siRNA delivery: Formulation and in vivo efficacy evaluation.

Chaharband F, Daftarian N, Kanavi MR, Varshochian R, Hajiramezanali M, Norouzi P, Arefian E, Atyabi F, Dinarvand R. Chaharband F, et al. Among authors: hajiramezanali m. Nanomedicine. 2020 Jun;26:102181. doi: 10.1016/j.nano.2020.102181. Epub 2020 Mar 10. Nanomedicine. 2020. PMID: 32169399

5

Design, preparation and biological evaluation of a ¹⁷⁷Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumors.

Behnammanesh H, Jokar S, Erfani M, Geramifar P, Sabzevari O, Amini M, Mazidi SM, Hajiramezanali M, Beiki D. Behnammanesh H, et al. Among authors: hajiramezanali m. Bioorg Chem. 2020 Jan;94:103381. doi: 10.1016/j.bioorg.2019.103381. Epub 2019 Oct 22. Bioorg Chem. 2020. PMID: 31662215

6

Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen.

Mosayebnia M, Hajimahdi Z, Beiki D, Rezaeianpour M, Hajiramezanali M, Geramifar P, Sabzevari O, Amini M, Hatamabadi D, Shahhosseini S. Mosayebnia M, et al. Among authors: hajiramezanali m. Bioorg Chem. 2020 Jun;99:103743. doi: 10.1016/j.bioorg.2020.103743. Epub 2020 Mar 13. Bioorg Chem. 2020. PMID: 32217372

7

Synthesis, biological evaluation and preclinical study of a novel ^99mTc-peptide: A targeting probe of amyloid-β plaques as a possible diagnostic agent for Alzheimer's disease.

Jokar S, Behnammanesh H, Erfani M, Sharifzadeh M, Gholami M, Sabzevari O, Amini M, Geramifar P, Hajiramezanali M, Beiki D. Jokar S, et al. Among authors: hajiramezanali m. Bioorg Chem. 2020 Jun;99:103857. doi: 10.1016/j.bioorg.2020.103857. Epub 2020 Apr 18. Bioorg Chem. 2020. PMID: 32330736

8

Development of a T Cell-targeted siRNA Delivery System Against HIV-1 Using Modified Superparamagnetic Iron Oxide Nanoparticles: An In Vitro Study.

Kamalzare S, Iranpur Mobarakeh V, Mirzazadeh Tekie FS, Hajiramezanali M, Riazi-Rad F, Yoosefi S, Normohammadi Z, Irani S, Tavakoli M, Rahimi P, Atyabi F. Kamalzare S, et al. Among authors: hajiramezanali m. J Pharm Sci. 2022 May;111(5):1463-1469. doi: 10.1016/j.xphs.2021.10.018. Epub 2021 Oct 19. J Pharm Sci. 2022. PMID: 34673092

9

Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells.

Karpisheh V, Fakkari Afjadi J, Nabi Afjadi M, Haeri MS, Abdpoor Sough TS, Heydarzadeh Asl S, Edalati M, Atyabi F, Masjedi A, Hajizadeh F, Izadi S, Mirzazadeh Tekie FS, Hajiramezanali M, Sojoodi M, Jadidi-Niaragh F. Karpisheh V, et al. Among authors: hajiramezanali m. Int J Biol Macromol. 2021 Jan 15;167:1006-1019. doi: 10.1016/j.ijbiomac.2020.11.056. Epub 2020 Nov 20. Int J Biol Macromol. 2021. PMID: 33227333

10

Preclinical study of a new ¹⁷⁷Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cells.

Behnammanesh H, Erfani M, Hajiramezanali M, Jokar S, Geramifar P, Sabzevari O, Amini M, Mazidi SM, Beiki D. Behnammanesh H, et al. Among authors: hajiramezanali m. Asia Ocean J Nucl Med Biol. 2020 Spring;8(2):109-115. doi: 10.22038/AOJNMB.2020.44432.1299. Asia Ocean J Nucl Med Biol. 2020. PMID: 32714998 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters